GEODE CAPITAL MANAGEMENT, LLC

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1214717 BOSTON, MA

Back to RARE Full portfolio

Position in RARE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$38,744,740

-$3,534,044 QoQ

Shares Held

1,849,391

+0.6% QoQ

Ownership

1.88%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in RARE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $18,580,924,343 across 526 Biotechnology names. RARE ranks #83 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,139,621	$2,741,586,360
2	REGN	Regeneron Pharmaceuticals, Inc.	2,607,732	$2,014,838,051
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,660,385	$880,241,584
4	INSM	INSMED Inc	4,450,389	$727,727,608
5	MRNA	Moderna, Inc.	9,435,132	$479,304,705
6	INCY	Incyte Corp	4,703,184	$442,663,677
7	RPRX	Royalty Pharma plc	7,869,632	$377,506,246
8	BBIO	BridgeBio Pharma, Inc.	4,918,030	$365,212,906

All Filings in RARE

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$38,744,740	1,849,391	+0.6%	Shares	Defined	2026-05-15
2025-12-31	$42,278,784	1,838,208	+16.3%	Shares	Defined	2026-02-09
2025-09-30	$47,541,650	1,580,507	-7.7%	Shares	Defined	2025-11-12
2025-06-30	$62,282,170	1,712,931	+4.0%	Shares	Defined	2025-08-08
2025-03-31	$59,621,104	1,646,537	+5.4%	Shares	Defined	2025-05-13
2024-12-31	$65,746,574	1,562,790	-0.5%	Shares	Defined	2025-02-12
2024-09-30	$87,273,548	1,571,081	+4.4%	Shares	Defined	2024-11-12
2024-06-30	$61,874,322	1,505,458	+12.4%	Shares	Defined	2024-08-09
2024-03-31	$62,556,475	1,339,826	+4.4%	Shares	Defined	2024-05-13
2023-12-31	$61,382,804	1,283,622	+18.5%	Shares	Defined	2024-02-13
2023-09-30	$38,619,181	1,083,287	+2.1%	Shares	Defined	2023-11-13
2023-06-30	$48,926,077	1,060,613	+4.5%	Shares	Defined	2023-08-11
2023-03-31	$40,687,064	1,014,640	+3.2%	Shares	Defined	2023-05-15
2022-12-31	$45,543,779	983,030	+6.3%	Shares	Defined	2023-02-13
2022-09-30	$38,299,156	924,877	+1.8%	Shares	Defined	2022-11-14
2022-06-30	$54,213,817	908,713	+0.6%	Shares	Defined	2022-08-12
2022-03-31	$65,568,598	902,900	+3.0%	Shares	Defined	2022-05-13
2021-12-31	$73,743,230	876,956	+3.7%	Shares	Defined	2022-02-11
2021-09-30	$76,306,782	846,067	+3.8%	Shares	Defined	2021-11-12
2021-06-30	$77,729,224	815,199	-24.3%	Shares	Defined	2021-08-13
2021-03-31	$122,574,047	1,076,533	+10.2%	Shares	Defined	2021-05-12
2020-12-31	$135,248,739	977,019	+13.8%	Shares	Defined	2021-02-12
2020-09-30	$70,584,525	858,797	+0.1%	Shares	Defined	2020-11-13
2020-06-30	$67,097,272	857,802	+5.0%	Shares	Defined	2020-08-13
2020-03-31	$36,298,199	816,975	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.